chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lost her sense of smell; sense of taste is limited and makes eating quite unpleasant; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), on 21Jul2022 as dose number unknown, single (Lot number: FP7135) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANOSMIA (non-serious) with onset 2022, outcome "unknown", described as "lost her sense of smell"; TASTE DISORDER (non-serious) with onset 2022, outcome "unknown", described as "sense of taste is limited and makes eating quite unpleasant". Additional information: Received the Pfizer vaccine on 21Jul2022. A few days after this vaccine patient lost her sense of smell. Her sense of taste is limited and makes eating quite unpleasant. It has been almost a year since this vaccine and her senses have not returned. She have never had COVID, only COVID vaccines. Her life is diminished due to this issue.
Rapid heart rate (160+ bpm), sharp pain when breathing, heart pounding in ears, (Woke up at 5 am with these symptoms.)
I went home about 8 minutes later. I was having trouble breathing and I was really Tired. I laid on the couch. I woke up at 07:30pm and was still feeling short of breath. By the next evening, I was having fever and having flu like symptoms. By Monday it was a little harder to breathe. I used my inhaler and I believe it was progressively getting worse, and went to  the ER, I was seeing sparkles and having tunnel vision and had to drive back home, 911 was called and I vaguely remember what was happening and I had to give permission to be put on the ventilator because my breathing was declining. At the ER I was put was put on Albuterol for 6 hours. I was having breathing issues; it was not an asthma attack. When I was finally able to talk to them, I told them I was vaccinated, and they said not to get the shot again. They got my breathing together and my blood pressure down. They were comfortable letting me go home. My doctor was not 100% sure that it was the vaccine, but it was something to do with that.  I was given a steroids' and a Z pack and told to follow up. It seems that my immune system was healthy like I was before. I am active and now I do not have the same amount of energy. It does not take long for me to be short of breath. I get out of breath walking to my mailbox now. It was almost it was really bad after the vaccine and it slowly goes away. I feel like my system is not healthy.    12/20/2021 - I contracted covid. I had headache, and neck pain. I was not nearly as sick as my husband
This case was reported by a pharmacist via call center representative and described the occurrence of neck swelling in a 53-year-old female patient who received SHINGRIX (batch number 9AS39, expiry date 13th July 2020) for prophylaxis. On 9th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 9th May 2018, immediately after receiving SHINGRIX, the patient experienced injection site pain. In May 2018, the patient experienced neck swelling and general body pain. On an unknown date, the outcome of the neck swelling, general body pain and injection site pain were recovered/resolved. The reporter considered the neck swelling, general body pain and injection site pain to be probably related to SHINGRIX. Additional details were provided as follows: The health care professional reported that patient received the first dose of SHINGRIX and experienced swelling of the neck which led to body pains. The patient experienced a lot of pain when receiving the vaccine as well. As per health care professional, she acted like the vaccine really hurt her. The reaction started within 24 hours and lasted a few days. It was resolved at the point of reporting. She went to see her doctor who prescribed her antihistamines.
pt recv vax & exp hives 2 days p/vax;became progressively worse;tx w/oral DPH in ER:pt believes that hives would have subsided if untreated but DPH helped;pt not sure if hives caused by vax, but can not attribute them to any other cau
Information has been received from a dentist concerning his 18 year old daughter with soft sound sensitivity syndrome (Hyperacusis), who, on an unspecified date was vaccinated with a first and second dose of Gardasil (Lot# 656050/0245U).  Subsequently the patient experienced a decline in her energy levels.  On 19-DEC-2007 the patient was vaccinated IM with a third 0.5mL dose of Gardasil (Lot# 656050/0245U).  Concomitant therapy included LEXAPRO and ROZEREM.  Subsequently, in the beginning of January, one to two weeks post vaccination the patient became experienced lethargy characterized by falling asleep in class and sleeping through meals.  It was reported that the patient "could not lift her head off the pillow some days."  The patient was examined by a physician.  A thyroid function test, mononucleosis serology test, complete blood cell count, and Lyme disease enzyme-linked immunosorbent assay were performed and were negative.  A "full blood work-up" was performed.  A sleep study was performed and was negative.  It was reported that the patient has not received any new medications.  At the time of the report the patient had not recovered.  No product quality complaint was involved.  The decreased energy levels and the patient becoming extremely lethargic were considered to be disabling.  Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a 81 year old female patient with diabetes mellitus, hyperlipidaemia, hypertension, osteopenia, gout, gastrooesophageal reflux disease (GERD) and an allergy to GLUCOPHAGE. On 15-JUL-2015, the patient visited physician's office with nasal congestion, runny nose, sore throat, both dry and productive cough lasting for 3 days and was diagnosed with upper respiratory infection (captured in MARRS#1507USA010143). On 15-JUL-2015, on the same visit, the patient was vaccinated with PNEUMOVAX 23 lot # K021030, intramuscular in the left arm. Concomitant therapies included COLCRYS, amlodipine besylate, fosinopril sodium, hydrochlorothiazide, meclizine hydrochloride and allopurinol. On 15-JUL-2015, several hours after vaccination, the patient reported that her entire left arm was sore and she could barely pick it up and she experienced headache. As treatment, patient was instructed to put ice on her deltoid region and perform active and passive range-of-motion exercises. The patient did not recover from adverse events at the time of this report. Causality assessment was not provided. This is one of several reports from the same reporter. Additional information has been requested.
Dizzy, vision blurry.  BP140/98 P118.  Rest, juice. Felt better, called contact for pick-up. BP119/98, P95 @1:10pm.  Feeling better but still feels slight dizziness. Transported via w/chair to ride w/brother.
Patient noticed rash on left arm at injection site circular rash 1 1/2 inches to 2 inches diameter. Warm to touch, sensitive> Noticed 2 days later 11/25/15. Saw dr on same day 11/25/15.Dr prescribed antibiotic (cephalexin) and TYLENOL. Rash cleared up by next day - 11/26/15 per patient.
Engerix-B -Inappropriate Schedule/ 3rd dose received in Oct 2021; Engerix-B -Inappropriate Schedule/ 2nd dose received in Sep 2021; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 13-year-old female patient who received HBV (Engerix B) (batch number F22EZ, expiry date 3rd June 2023) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix B (1st dose received in 2008).   On 5th October 2021, the patient received the 3rd dose of Engerix B. In September 2021, the patient received the 2nd dose of Engerix B. In September 2021, not applicable after receiving Engerix B and unknown after receiving Engerix B, the patient experienced drug dose administration interval too long. On 5th October 2021, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short and drug dose administration interval too long were unknown.  Additional details were provided as follows: The Nurse Practitioner reported that, the patient began the Engerix-B series in 2008, received the second dose was on September2021, which led to lengthening of vaccination schedule. The patient received the third dose on the day before reporting date, which was earlier from 2nd dose and led to shortening of vaccination schedule. The reporter consented to follow up.
Experienced Fever / Sore arm at injection site /  am a cardio patient with aICD installed/  Experienced mild heart Chest pains  Shortness of breath Feelings of having a fast-beating, fluttering, or pounding heart.. momentarily used blood PSI check that has heart rate and any iregular heart arrithmia's  didn't detect anything ,.  Blood PSI were elevated levels  133/90  ..  symtoms went away after a week and half to two weeks after injections of the 2nd and 3rd booster shots,.  nothing to warrant a doctors or hospital visit ..   as a percaution I talked it over with my Cardio Dr about being re-prescribed Plavix to take a week prior to any of the vacinations being done and continued for two weeks after each time  I Can Recomend threw personal expirence that Persons with Heart and or high Blood PSI  issues be on Plavix a Week  before reciving any of the Covid 19  Shots and to see there doctors to review or update there current Rx's   to avoid an emergency room or urgent care Visits,.
Multiple vesicles to (R) flank, back, chest & face. Clear fluid expressed. Treatment: (1) acyclovir 200 mg/5cc; 15 cc po Q6 hour x 5 day. (2) ATARAX 100 mg/5 cc; 5 cc po q 8 hours prn. Lab result is positive for varicella zoster.
he does not feel so great; eyes are aching; malaise; it was very difficult getting out of bed now; it was very difficult sleeping at night; headache after the third dose; fever (not high) after the third dose; aches after the third dose,pains after the third dose; joint stiffness after the third dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches after the third dose,pains after the third dose), JOINT STIFFNESS (joint stiffness after the third dose), MALAISE (he does not feel so great), EYE PAIN (eyes are aching) and MALAISE (malaise) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN and CITALOPRAM for an unknown indication.    On 27-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced PAIN (aches after the third dose,pains after the third dose), JOINT STIFFNESS (joint stiffness after the third dose), HEADACHE (headache after the third dose) and PYREXIA (fever (not high) after the third dose). On 28-Sep-2021, the patient experienced MALAISE (he does not feel so great), EYE PAIN (eyes are aching), MALAISE (malaise), MOBILITY DECREASED (it was very difficult getting out of bed now) and INSOMNIA (it was very difficult sleeping at night). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 500 milligram. At the time of the report, PAIN (aches after the third dose,pains after the third dose), JOINT STIFFNESS (joint stiffness after the third dose), MALAISE (he does not feel so great), EYE PAIN (eyes are aching), MALAISE (malaise), MOBILITY DECREASED (it was very difficult getting out of bed now), INSOMNIA (it was very difficult sleeping at night), HEADACHE (headache after the third dose) and PYREXIA (fever (not high) after the third dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had the third dose yesterday at 3pm and now 21 hours later, did not feel so great, eyes were aching, malaise, it was very difficult getting out of bed and sleeping at night. Unknown immunocompromised status of receiving third dose.   This case was linked to MOD-2021-335120, MOD-2021-335133 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up information: Unknown immunocompromised status receiving third dose.
Patient inadvertently received pediatric Hepatitis A (12mo-18years)(0.5ml), rather that adult Hepatitis A (>19yrs)(1.0ml). Will contact patient to return to clinic for full therapeutic dose of Hep A.
Patient developed fever 100-101, fussiness, and tenderness at immunization sites (both legs) and refused to bear weight on evening of 3/31/2010. Patient seen 4/1/10 in clinic; 101.3F, fussy & upper airway rhonchi, ears (-), lungs (-), (+) induration of thighs. (R) thigh: 3cm induration, no redness, mild tenderness. (L) thigh 5x3cm induration (both injection sites centered within induration), mild warmth, minimal redness, mild tenderness, no fluctuance. Neuro exam: alert, nl DTR's (normal), refused to bear weight.
Information has been received from a physician concerning a 24 year old female with no pertinent medical history and no drug reactions/allergies, who on 12-JUL-2007 and 03-OCT-2007 was vaccinated with a first and second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (rHA) (lot number: 655280/1458) (both vaccinations were with the same lot). There was no concomitant medication. The physician reported that the patient received at least 2 vaccinations and had a negative mumps titer. The patient may have received the vaccine as a child. No information was provided on testing or titers prior to recent vaccinations. No problems were reported. No other information was reported. Lab diagnostic studies performed included: negative titer for mumps. Unspecified medical attention was sought. Outcome reported as: negative titer for mumps. There was no product quality complaint. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to an approximately 70 year old female patient. Medical history and drug reactions/allergies were not reported. On 23-OCT-2013, the patient was vaccinated with PNEUMOVAX23 lot # H013399 exp date 07-MAR-2014 (dose and route not reported). It was unknown if this was the patient's first administration of PNEUMOVAX23. There was no concomitant medication. In October 2013 (the patient called to the pharmacy on 28-OCT-2013), the patient was unable to move the arm that the PNEUMOVAX23 was administered. The patient sought for medical attention (pharmacy call). No treatment given for the events. No lab diagnostics performed. The outcome of the event was reported as not recovered. Additional information has been requested.
Patient received Monovalent for booster vaccine, under new CDC guidelines patient should have received Bivalent. Patient called and informed she will qualify for Bivalent after 11/01/2022, patient declined at this time.
Patient was given Pneumovax23 IM shot at 2:30 PM and then left immunization room to purchase others things . She came back to the pharmacy ~minutes later reporting a pounding heartbeat, flushing in the face, and shortness of breath.  I promptly took the patient back into the immunization room and elevated her legs while locating EpiPen. Redness in patient's face diminished over the next 5 to 10 minutes and she no longer reported shortness of breath or racing heart beat. Pt reported that she had been to DR office earlier where she had blood drawn. We provided water and pt had purchased a small candy bar which ate part of. Pt was okay to try and walk to front of store again after about 15 from incident starting. She said she was feeling better and purchased her items and left the store under her own will.
Patient was given Zostavax instead of varicella on 07/30/08. Mother contacted, no adverse reaction noted. Merck contacted and ok to count as second dose of varicella as patient had received 1 previous dose of varicella.
2+ weeks after 1st dose = Extreme hot flash and then difficulty breathing..... 22 days after 2nd dose = Extreme hot flash and could not get breath - continuing SEVERE difficulty breathing.
pt recvd vax; subsequently she devel hoarseness which also persisted to the date of this report;
Extreme gas, gas pains and bloating for 12 hours; Extreme gas, gas pains and bloating for 12 hours; Body aches and extreme tired for 48 hours; Body aches and extreme tired for 48 hours; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 07May2021 at 11:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fish oil (OMEGA 3), pre/probiotic (MANUFACTURER UNKNOWN) and unspecified multivitamin (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 15:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation.  The patient previously received oseltamivir phosphate (TAMIFLU) and experienced drug allergy. On 07May2021 at 16:00, the patient experienced extreme gas, gas pains and bloating for 12 hours and body aches and extreme tired for 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL) and bismuth subsalicylate (PEPTO BISMOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme gas, gas pains and bloating for 12 hours was resolved on 08May2021 at 04:00 while that off body aches and extreme tired for 48 hours was resolved on 09May2021 at 16:00.  No follow-up attempts are needed. No further information is expected.
within about 2 hours, patient developed headache and mild achiness.  Approximately 12 hours later, significant chills, fever 103.5, skin painful to touch, nausea, chest tightness, severe headache, significant muscle and joint pain. Patient took tylenol with no benefit.  symptoms persisted approximately 6 hours then improved to fatigue, nausea, mild headache, muscle and joint tenderness that increased again during the night.  symptoms persisted in this pattern for approximately 72 hours. fatigue lasted about 5 days.
chills, sweats, (no fever), severe stomach cramping, vomiting for 24 hours, called immunologist, prescribed medication to stop nausea, son had to drive 4 hours to be with me for 48 hours until I could hold liquids.  Day 4 after onset much better. Day 5, getting back to normal.
In the evening after receiving injection patient broke out in a rash, lips began to become swollen, little bit of trouble breathing and heartburn all night. Following day patient went in to for appointment at Doctor's office and was given a prescription for Zyrtec 10 mg to take twice daily. By time patient came in to pick up prescription in the evening lips were no longer swollen and no trouble breathing.
dizziness; lethargic; numbness in the arms and legs; difficulty focusing; shortness of breath; swelling in the throat area; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), LETHARGY (lethargic), HYPOAESTHESIA (numbness in the arms and legs), VISION BLURRED (difficulty focusing) and DYSPNOEA (shortness of breath) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced DIZZINESS (dizziness), LETHARGY (lethargic), HYPOAESTHESIA (numbness in the arms and legs), VISION BLURRED (difficulty focusing), DYSPNOEA (shortness of breath) and PHARYNGEAL SWELLING (swelling in the throat area). At the time of the report, DIZZINESS (dizziness), LETHARGY (lethargic), HYPOAESTHESIA (numbness in the arms and legs), VISION BLURRED (difficulty focusing), DYSPNOEA (shortness of breath) and PHARYNGEAL SWELLING (swelling in the throat area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow-up received on 23-04-2021: SD contains new info abt lot number, SD and Email document attached
Received her COVID-19 vaccine. Patient  stated "within 10 mins of receiving the vaccine, I started feeling like I'm going to have an asthma attack." She reported having headache, chills, her heart  racing, "I feel like my airway is closing that I had to cough".  Vital signs were taken by staff at the clinic. Patient reported BP was elevated, HR elevated, but O2 Sat was 100%.  Within 15 mins symptoms resolved. Patient returned to  her work area in the ED that same morning.  During her shift she took Motrin for a  headache.  On 1/8/21, @ 2330 started feeling burning sensation on the injection site, noticed that there was a blister and redness on the area. . 1/11/2021, she reported redness at the injection.  All other symptoms resolved on its own.
MMR admin. 01-10-06......Measles like rash over enter body 01-20-06......low grade fever....trip to hospital 01-21-06.....not eating normally...not sleeping normaly........emergency room suggested antihistamine if nessary.
After flu shot my arm was very sore. It was much worse the next morning. The pain was in my shoulder, arm, elbow and back. There was a severe weakness in my arm. It is still in my arm and I use my right hand to move my left. It moves better when I am upright and I try to exercise the arm a little. It is painful and frightening. When I can't take it I take Ibuprofen.
sz-high temp-convuls;was taken to hosp immed now has ongoing sz to date on meds constantly w/other problems;